The biologics fermentation capacity market is projected to reach $32.4 billion by 2036, at a CAGR of 12.6% from 2026 to 2036. The growth of this market is primarily fueled by a record biologics pipeline, rapid adoption of single-use and modular bioprocessing technology, and government-backed reshoring of domestic biomanufacturing capacity. Additionally, the FDA's Center for Biologics Evaluation and Research approving 24 new Biologics License Applications in 2024, including a record 13 new monoclonal antibodies, and continued platform broadening across scales by leading equipment manufacturers are expected to create substantial growth opportunities for market participants.
The key players operating in the biologics fermentation capacity market are Sartorius AG (Germany), Danaher Corporation/Cytiva (U.S.), Thermo Fisher Scientific Inc. (U.S.), Merck KGaA (Germany), Eppendorf SE (Germany), ABEC, Inc. (U.S.), Getinge AB (Sweden), Tofflon Science and Technology Co., Ltd. (China), GEA Group Aktiengesellschaft (Germany), Pierre Guérin (France), ZETA GmbH (Austria), Bioengineering AG (Switzerland), INFORS HT (Switzerland), PBS Biotech, Inc. (U.S.), bbi-biotech GmbH (Germany), and Solaris Biotech Solutions S.r.l. (Italy).
The biologics fermentation capacity market study presents historical market data value (2025), estimated current data (2026), and forecasts for 2036. This market is segmented by system type, scale of operation, mode of operation, cell/organism type, application, end user, and geography.
Among all the system types, Single-Use Bioreactor Systems are expected to account for the largest share of installed capacity additions through most of the forecast period, reflecting their lower capital intensity and faster commissioning timelines relative to conventional stainless-steel facilities. Hybrid Systems, which combine single-use flexibility with stainless-steel scale, represent the fastest-growing system category, as large-scale commercial manufacturers balance speed-to-capacity with the economics of high-volume production.
Recent platform activity underscores this shift: Thermo Fisher Scientific introduced its 5-liter DynaDrive single-use bioreactor in February 2026 for small-scale, GMP-ready bioprocessing, while Cytiva expanded its Xcellerex platform with 500-liter and 2,000-liter single-use systems in March 2025. FUJIFILM Diosynth Biotechnologies is separately expanding its Hillerød, Denmark site to twelve 20,000-liter mammalian cell bioreactors with integrated fill-finish capability, one of the largest single biologics drug substance capacity investments underway in Europe.
Among all the geographies, North America and Europe together hold the largest revenue share of the biologics fermentation capacity market in 2026, supported by dense CDMO networks and high regulatory approval volumes. Asia-Pacific, however, is expected to register the fastest CAGR during the forecast period, driven by large-scale capacity build-out in China and South Korea and national bulk drug and biopharma manufacturing incentive programmes in India, including the Department of Pharmaceuticals' Production Linked Incentive Scheme for Bulk Drugs, which carries a financial outlay of ₹6,940 crore and requires a minimum domestic value addition of 90% for fermentation-based products.
Policy support is also reinforcing capacity growth across regions. In the United States, the National Institute for Innovation in Manufacturing Biopharmaceuticals has awarded more than $111 million across over 120 biopharmaceutical manufacturing technology and workforce projects since its 2017 launch. In the European Union, the European Commission proposed the European Biotech Act on December 16, 2025, alongside the earlier Critical Medicines Act of March 2025, both aimed at expanding EU biomanufacturing capacity through fast-tracked permitting and targeted financial support.
The key players operating in the biologics fermentation capacity market are Sartorius AG (Germany), Danaher Corporation/Cytiva (U.S.), Thermo Fisher Scientific Inc. (U.S.), Merck KGaA (Germany), Eppendorf SE (Germany), ABEC, Inc. (U.S.), Getinge AB (Sweden), Tofflon Science and Technology Co., Ltd. (China), GEA Group Aktiengesellschaft (Germany), Pierre Guérin (France), ZETA GmbH (Austria), Bioengineering AG (Switzerland), INFORS HT (Switzerland), PBS Biotech, Inc. (U.S.), bbi-biotech GmbH (Germany), and Solaris Biotech Solutions S.r.l. (Italy).
The biologics fermentation capacity market study presents historical market data value (2025), estimated current data (2026), and forecasts for 2036. This market is segmented by system type, scale of operation, mode of operation, cell/organism type, application, end user, and geography.
Among all the system types, Single-Use Bioreactor Systems are expected to account for the largest share of installed capacity additions through most of the forecast period, reflecting their lower capital intensity and faster commissioning timelines relative to conventional stainless-steel facilities. Hybrid Systems, which combine single-use flexibility with stainless-steel scale, represent the fastest-growing system category, as large-scale commercial manufacturers balance speed-to-capacity with the economics of high-volume production.
Recent platform activity underscores this shift: Thermo Fisher Scientific introduced its 5-liter DynaDrive single-use bioreactor in February 2026 for small-scale, GMP-ready bioprocessing, while Cytiva expanded its Xcellerex platform with 500-liter and 2,000-liter single-use systems in March 2025. FUJIFILM Diosynth Biotechnologies is separately expanding its Hillerød, Denmark site to twelve 20,000-liter mammalian cell bioreactors with integrated fill-finish capability, one of the largest single biologics drug substance capacity investments underway in Europe.
Among all the geographies, North America and Europe together hold the largest revenue share of the biologics fermentation capacity market in 2026, supported by dense CDMO networks and high regulatory approval volumes. Asia-Pacific, however, is expected to register the fastest CAGR during the forecast period, driven by large-scale capacity build-out in China and South Korea and national bulk drug and biopharma manufacturing incentive programmes in India, including the Department of Pharmaceuticals' Production Linked Incentive Scheme for Bulk Drugs, which carries a financial outlay of ₹6,940 crore and requires a minimum domestic value addition of 90% for fermentation-based products.
Policy support is also reinforcing capacity growth across regions. In the United States, the National Institute for Innovation in Manufacturing Biopharmaceuticals has awarded more than $111 million across over 120 biopharmaceutical manufacturing technology and workforce projects since its 2017 launch. In the European Union, the European Commission proposed the European Biotech Act on December 16, 2025, alongside the earlier Critical Medicines Act of March 2025, both aimed at expanding EU biomanufacturing capacity through fast-tracked permitting and targeted financial support.
Key Questions Answered in the Report:
- What is the current revenue generated by the biologics fermentation capacity market globally?
- At what rate is the biologics fermentation capacity market demand projected to grow for the next 10 years?
- What are the historical market sizes and growth rates of the biologics fermentation capacity market?
- What are the major factors impacting the growth of this market at the regional and country levels? What are the major opportunities for existing players and new entrants in the market?
- Which segments in terms of system type, scale of operation, mode of operation, cell/organism type, application, and end user are expected to create major traction for the manufacturers in this market?
- What are the key geographical trends in this market? Which regions/countries are expected to offer significant growth opportunities for the manufacturers operating in the biologics fermentation capacity market?
- Who are the major players in the biologics fermentation capacity market? What are their specific product offerings in this market?
- What are the recent strategic developments in the biologics fermentation capacity market? What are the impacts of these strategic developments on the market?
Table of Contents
1. Introduction
1.1. Market Definition
1.2. Currency & Limitations
1.2.1. Currency
1.2.2. Limitations
1.2. Currency & Limitations
1.2.1. Currency
1.2.2. Limitations
2. Research Methodology
2.1. Research Approach
2.2. Data Collection & Validation
2.2.1. Secondary Research
2.2.2. Primary Research
2.3. Market Assessment
2.3.1. Market Size Estimation
2.3.2. Bottom-Up Approach
2.3.3. Top-Down Approach
2.3.4. Growth Forecast
2.4. Assumptions for the Study
2.2. Data Collection & Validation
2.2.1. Secondary Research
2.2.2. Primary Research
2.3. Market Assessment
2.3.1. Market Size Estimation
2.3.2. Bottom-Up Approach
2.3.3. Top-Down Approach
2.3.4. Growth Forecast
2.4. Assumptions for the Study
4. Market Insights
4.1. Overview
4.2. Factors Affecting Market Growth
4.2.1. Drivers
4.2.1.1. Surging Biologics Pipeline and Record Regulatory Approvals
4.2.1.2. Rapid Adoption of Single-Use and Modular Bioprocessing Technology
4.2.1.3. Government-Backed Reshoring and Public-Private Investment in Domestic Biomanufacturing
4.2.2. Restraints
4.2.2.1. High Capital Intensity and Long Gestation Periods for Capacity Buildout
4.2.3. Opportunities
4.2.3.1. Expansion of Fermentation Capacity for Cell and Gene Therapy and Next-Generation Modalities
4.2.3.2. Localization of Biomanufacturing Capacity in Emerging Markets
4.2.4. Challenges
4.2.4.1. Shortage of Skilled Bioprocessing Workforce and Engineering Talent Expected to Remain a Major Challenge
4.3. Key Trends
4.3.1. Shift Toward Hybrid Facility Designs Combining Single-Use Flexibility with Stainless-Steel Scale
4.3.2. Rise of Continuous Bioprocessing and Process Intensification
4.4. Vendor Selection Criteria/Factors Influencing Purchase Decisions
4.5. Use Cases
4.6. Porter's Five Forces Analysis
4.6.1. Bargaining Power of Buyers: Moderate
4.6.2. Bargaining Power of Suppliers: Moderate to High
4.6.3. Threat of Substitutes: Low to Moderate
4.6.4. Threat of New Entrants: Moderate
4.6.5. Degree of Competition: High
4.7. Value Chain Analysis
4.8. Pricing Analysis (Single-Use vs. Stainless-Steel Capital and Operating Cost Comparison)
4.9. Technology Analysis (Traditional Stirred-Tank vs. Single-Use, Vertical-Wheel, and Advanced Therapy Bioreactor Platforms)
4.10. Facility Design and Commissioning Timeline Analysis
4.11. Regulatory Landscape (U.S. FDA/CBER, EU Critical Medicines Act & European Biotech Act, India Fertilizer & Pharmaceutical PLI Frameworks, Other National Biomanufacturing Programmes)
4.12. Government Subsidy and Incentive Landscape
4.13. PESTEL Analysis
4.2. Factors Affecting Market Growth
4.2.1. Drivers
4.2.1.1. Surging Biologics Pipeline and Record Regulatory Approvals
4.2.1.2. Rapid Adoption of Single-Use and Modular Bioprocessing Technology
4.2.1.3. Government-Backed Reshoring and Public-Private Investment in Domestic Biomanufacturing
4.2.2. Restraints
4.2.2.1. High Capital Intensity and Long Gestation Periods for Capacity Buildout
4.2.3. Opportunities
4.2.3.1. Expansion of Fermentation Capacity for Cell and Gene Therapy and Next-Generation Modalities
4.2.3.2. Localization of Biomanufacturing Capacity in Emerging Markets
4.2.4. Challenges
4.2.4.1. Shortage of Skilled Bioprocessing Workforce and Engineering Talent Expected to Remain a Major Challenge
4.3. Key Trends
4.3.1. Shift Toward Hybrid Facility Designs Combining Single-Use Flexibility with Stainless-Steel Scale
4.3.2. Rise of Continuous Bioprocessing and Process Intensification
4.4. Vendor Selection Criteria/Factors Influencing Purchase Decisions
4.5. Use Cases
4.6. Porter's Five Forces Analysis
4.6.1. Bargaining Power of Buyers: Moderate
4.6.2. Bargaining Power of Suppliers: Moderate to High
4.6.3. Threat of Substitutes: Low to Moderate
4.6.4. Threat of New Entrants: Moderate
4.6.5. Degree of Competition: High
4.7. Value Chain Analysis
4.8. Pricing Analysis (Single-Use vs. Stainless-Steel Capital and Operating Cost Comparison)
4.9. Technology Analysis (Traditional Stirred-Tank vs. Single-Use, Vertical-Wheel, and Advanced Therapy Bioreactor Platforms)
4.10. Facility Design and Commissioning Timeline Analysis
4.11. Regulatory Landscape (U.S. FDA/CBER, EU Critical Medicines Act & European Biotech Act, India Fertilizer & Pharmaceutical PLI Frameworks, Other National Biomanufacturing Programmes)
4.12. Government Subsidy and Incentive Landscape
4.13. PESTEL Analysis
5. Biologics Fermentation Capacity Market Assessment, by System Type
5.1. Overview
5.2. Single-Use (Disposable) Bioreactor Systems
5.3. Stainless Steel (Reusable) Bioreactor Systems
5.4. Hybrid Systems
5.2. Single-Use (Disposable) Bioreactor Systems
5.3. Stainless Steel (Reusable) Bioreactor Systems
5.4. Hybrid Systems
6. Biologics Fermentation Capacity Market Assessment, by Scale of Operation
6.1. Overview
6.2. Bench & Pilot Scale
6.3. Clinical Scale
6.4. Commercial/Large Scale
6.2. Bench & Pilot Scale
6.3. Clinical Scale
6.4. Commercial/Large Scale
7. Biologics Fermentation Capacity Market Assessment, by Mode of Operation
7.1. Overview
7.2. Batch
7.3. Fed-Batch
7.4. Perfusion/Continuous
7.2. Batch
7.3. Fed-Batch
7.4. Perfusion/Continuous
8. Biologics Fermentation Capacity Market Assessment, by Cell/Organism Type
8.1. Overview
8.2. Mammalian Cell Culture
8.3. Microbial Fermentation
8.4. Others (Insect Cell, Yeast & Alternative Platforms)
8.2. Mammalian Cell Culture
8.3. Microbial Fermentation
8.4. Others (Insect Cell, Yeast & Alternative Platforms)
9. Biologics Fermentation Capacity Market Assessment, by Application
9.1. Overview
9.2. Monoclonal Antibodies & Biosimilars
9.3. Vaccines
9.4. Cell & Gene Therapy
9.5. Recombinant Proteins & Enzymes
9.2. Monoclonal Antibodies & Biosimilars
9.3. Vaccines
9.4. Cell & Gene Therapy
9.5. Recombinant Proteins & Enzymes
10. Biologics Fermentation Capacity Market Assessment, by End User
10.1. Overview
10.2. CDMOs/CMOs
10.3. Biopharmaceutical & Biotechnology Companies
10.4. Academic & Research Institutes
10.2. CDMOs/CMOs
10.3. Biopharmaceutical & Biotechnology Companies
10.4. Academic & Research Institutes
11. Biologics Fermentation Capacity Market Assessment, by Geography
11.1. Overview
11.2. North America
11.2.1. United States
11.2.2. Canada
11.3. Europe
11.3.1. Germany
11.3.2. United Kingdom
11.3.3. France
11.3.4. Denmark
11.3.5. Switzerland
11.3.6. Italy
11.3.7. Rest of Europe
11.4. Asia-Pacific
11.4.1. China
11.4.2. South Korea
11.4.3. India
11.4.4. Japan
11.4.5. Australia & New Zealand
11.4.6. Rest of Asia-Pacific
11.5. Latin America
11.5.1. Brazil
11.5.2. Argentina
11.5.3. Mexico
11.5.4. Rest of Latin America
11.6. Middle East & Africa
11.6.1. Saudi Arabia
11.6.2. United Arab Emirates
11.6.3. South Africa
11.6.4. Rest of Middle East & Africa
11.2. North America
11.2.1. United States
11.2.2. Canada
11.3. Europe
11.3.1. Germany
11.3.2. United Kingdom
11.3.3. France
11.3.4. Denmark
11.3.5. Switzerland
11.3.6. Italy
11.3.7. Rest of Europe
11.4. Asia-Pacific
11.4.1. China
11.4.2. South Korea
11.4.3. India
11.4.4. Japan
11.4.5. Australia & New Zealand
11.4.6. Rest of Asia-Pacific
11.5. Latin America
11.5.1. Brazil
11.5.2. Argentina
11.5.3. Mexico
11.5.4. Rest of Latin America
11.6. Middle East & Africa
11.6.1. Saudi Arabia
11.6.2. United Arab Emirates
11.6.3. South Africa
11.6.4. Rest of Middle East & Africa
12. Competitive Landscape
12.1. Introduction
12.2. Key Growth Strategies
12.3. Competitive Benchmarking (System Type Coverage, Scale Range, Facility Footprint, Registered Geographies)
12.4. Competitive Dashboard
12.4.1. Industry Leaders
12.4.2. Market Differentiators
12.4.3. Vanguards
12.4.4. Emerging Companies
12.5. Market Share/Position Analysis
12.2. Key Growth Strategies
12.3. Competitive Benchmarking (System Type Coverage, Scale Range, Facility Footprint, Registered Geographies)
12.4. Competitive Dashboard
12.4.1. Industry Leaders
12.4.2. Market Differentiators
12.4.3. Vanguards
12.4.4. Emerging Companies
12.5. Market Share/Position Analysis
13. Company Profiles
13.1. Sartorius AG
13.1.1. Business Overview
13.1.2. Financial Overview
13.1.3. Product Portfolio
13.1.4. SWOT Analysis
13.1.5. Strategic Developments
13.2. Danaher Corporation/Cytiva
13.2.1. Business Overview
13.2.2. Financial Overview
13.2.3. Product Portfolio
13.2.4. SWOT Analysis
13.2.5. Strategic Developments
13.3. Thermo Fisher Scientific Inc.
13.3.1. Business Overview
13.3.2. Financial Overview
13.3.3. Product Portfolio
13.3.4. SWOT Analysis
13.3.5. Strategic Developments
13.4. Merck KGaA
13.4.1. Business Overview
13.4.2. Financial Overview
13.4.3. Product Portfolio
13.4.4. SWOT Analysis
13.4.5. Strategic Developments
13.5. Eppendorf SE
13.5.1. Business Overview
13.5.2. Financial Overview
13.5.3. Product Portfolio
13.5.4. SWOT Analysis
13.5.5. Strategic Developments
13.6. ABEC, Inc.
13.6.1. Business Overview
13.6.2. Product Portfolio
13.6.3. SWOT Analysis
13.6.4. Strategic Developments
13.7. Getinge AB
13.7.1. Business Overview
13.7.2. Financial Overview
13.7.3. Product Portfolio
13.7.4. SWOT Analysis
13.7.5. Strategic Developments
13.8. Tofflon Science and Technology Group Co., Ltd.
13.8.1. Business Overview
13.8.2. Financial Overview
13.8.3. Product Portfolio
13.8.4. SWOT Analysis
13.8.5. Strategic Developments
13.9. GEA Group Aktiengesellschaft
13.9.1. Business Overview
13.9.2. Financial Overview
13.9.3. Product Portfolio
13.9.4. SWOT Analysis
13.9.5. Strategic Developments
13.10. Pierre Guérin
13.10.1. Business Overview
13.10.2. Product Portfolio
13.10.3. SWOT Analysis
13.10.4. Strategic Developments
13.11. ZETA GmbH
13.11.1. Business Overview
13.11.2. Product Portfolio
13.11.3. SWOT Analysis
13.12. Bioengineering AG
13.12.1. Business Overview
13.12.2. Product Portfolio
13.12.3. SWOT Analysis
13.13. INFORS HT
13.13.1. Business Overview
13.13.2. Product Portfolio
13.13.3. SWOT Analysis
13.14. PBS Biotech, Inc.
13.14.1. Business Overview
13.14.2. Product Portfolio
13.14.3. SWOT Analysis
13.14.4. Strategic Developments
13.15. bbi-biotech GmbH
13.15.1. Business Overview
13.15.2. Product Portfolio
13.15.3. SWOT Analysis
13.16. Solaris Biotechnology S.r.l. (Donaldson Company, Inc.)
13.16.1. Business Overview
13.16.2. Financial Overview
13.16.3. Product Portfolio
13.16.4. SWOT Analysis
13.16.5. Strategic Developments
13.1.1. Business Overview
13.1.2. Financial Overview
13.1.3. Product Portfolio
13.1.4. SWOT Analysis
13.1.5. Strategic Developments
13.2. Danaher Corporation/Cytiva
13.2.1. Business Overview
13.2.2. Financial Overview
13.2.3. Product Portfolio
13.2.4. SWOT Analysis
13.2.5. Strategic Developments
13.3. Thermo Fisher Scientific Inc.
13.3.1. Business Overview
13.3.2. Financial Overview
13.3.3. Product Portfolio
13.3.4. SWOT Analysis
13.3.5. Strategic Developments
13.4. Merck KGaA
13.4.1. Business Overview
13.4.2. Financial Overview
13.4.3. Product Portfolio
13.4.4. SWOT Analysis
13.4.5. Strategic Developments
13.5. Eppendorf SE
13.5.1. Business Overview
13.5.2. Financial Overview
13.5.3. Product Portfolio
13.5.4. SWOT Analysis
13.5.5. Strategic Developments
13.6. ABEC, Inc.
13.6.1. Business Overview
13.6.2. Product Portfolio
13.6.3. SWOT Analysis
13.6.4. Strategic Developments
13.7. Getinge AB
13.7.1. Business Overview
13.7.2. Financial Overview
13.7.3. Product Portfolio
13.7.4. SWOT Analysis
13.7.5. Strategic Developments
13.8. Tofflon Science and Technology Group Co., Ltd.
13.8.1. Business Overview
13.8.2. Financial Overview
13.8.3. Product Portfolio
13.8.4. SWOT Analysis
13.8.5. Strategic Developments
13.9. GEA Group Aktiengesellschaft
13.9.1. Business Overview
13.9.2. Financial Overview
13.9.3. Product Portfolio
13.9.4. SWOT Analysis
13.9.5. Strategic Developments
13.10. Pierre Guérin
13.10.1. Business Overview
13.10.2. Product Portfolio
13.10.3. SWOT Analysis
13.10.4. Strategic Developments
13.11. ZETA GmbH
13.11.1. Business Overview
13.11.2. Product Portfolio
13.11.3. SWOT Analysis
13.12. Bioengineering AG
13.12.1. Business Overview
13.12.2. Product Portfolio
13.12.3. SWOT Analysis
13.13. INFORS HT
13.13.1. Business Overview
13.13.2. Product Portfolio
13.13.3. SWOT Analysis
13.14. PBS Biotech, Inc.
13.14.1. Business Overview
13.14.2. Product Portfolio
13.14.3. SWOT Analysis
13.14.4. Strategic Developments
13.15. bbi-biotech GmbH
13.15.1. Business Overview
13.15.2. Product Portfolio
13.15.3. SWOT Analysis
13.16. Solaris Biotechnology S.r.l. (Donaldson Company, Inc.)
13.16.1. Business Overview
13.16.2. Financial Overview
13.16.3. Product Portfolio
13.16.4. SWOT Analysis
13.16.5. Strategic Developments
14. Appendix
14.1. Available Customization
14.2. Related Reports
14.2. Related Reports
List of Tables
Table 1. Currency Conversion Rates Used in This Study
Table 2. Global Biologics Fermentation Capacity Market, by System Type, 2024-2036 (USD Million)
Table 3. Global Single-Use (Disposable) Bioreactor Systems Market, by Country/Region, 2024-2036 (USD Million)
Table 4. Global Stainless Steel (Reusable) Bioreactor Systems Market, by Country/Region, 2024-2036 (USD Million)
Table 5. Global Hybrid Systems Market, by Country/Region, 2024-2036 (USD Million)
Table 6. Global Biologics Fermentation Capacity Market, by Scale of Operation, 2024-2036 (USD Million)
Table 7. Global Bench & Pilot Scale Biologics Fermentation Capacity Market, by Country/Region, 2024-2036 (USD Million)
Table 8. Global Clinical Scale Biologics Fermentation Capacity Market, by Country/Region, 2024-2036 (USD Million)
Table 9. Global Commercial/Large Scale Biologics Fermentation Capacity Market, by Country/Region, 2024-2036 (USD Million)
Table 10. Global Biologics Fermentation Capacity Market, by Mode of Operation, 2024-2036 (USD Million)
Table 11. Global Batch Biologics Fermentation Capacity Market, by Country/Region, 2024-2036 (USD Million)
Table 12. Global Fed-Batch Biologics Fermentation Capacity Market, by Country/Region, 2024-2036 (USD Million)
Table 13. Global Perfusion/Continuous Biologics Fermentation Capacity Market, by Country/Region, 2024-2036 (USD Million)
Table 14. Global Biologics Fermentation Capacity Market, by Cell/Organism Type, 2024-2036 (USD Million)
Table 15. Global Mammalian Cell Culture Biologics Fermentation Capacity Market, by Country/Region, 2024-2036 (USD Million)
Table 16. Global Microbial Fermentation Biologics Fermentation Capacity Market, by Country/Region, 2024-2036 (USD Million)
Table 17. Global Others (Insect Cell, Yeast & Alternative Platforms) Biologics Fermentation Capacity Market, by Country/Region, 2024-2036 (USD Million)
Table 18. Global Biologics Fermentation Capacity Market, by Application, 2024-2036 (USD Million)
Table 19. Global Monoclonal Antibodies & Biosimilars Biologics Fermentation Capacity Market, by Country/Region, 2024-2036 (USD Million)
Table 20. Global Vaccines Biologics Fermentation Capacity Market, by Country/Region, 2024-2036 (USD Million)
Table 21. Global Cell & Gene Therapy Biologics Fermentation Capacity Market, by Country/Region, 2024-2036 (USD Million)
Table 22. Global Recombinant Proteins & Enzymes Biologics Fermentation Capacity Market, by Country/Region, 2024-2036 (USD Million)
Table 23. Global Biologics Fermentation Capacity Market, by End User, 2024-2036 (USD Million)
Table 24. Global CDMOs/CMOs Biologics Fermentation Capacity Market, by Country/Region, 2024-2036 (USD Million)
Table 25. Global Biopharmaceutical & Biotechnology Companies Biologics Fermentation Capacity Market, by Country/Region, 2024-2036 (USD Million)
Table 26. Global Academic & Research Institutes Biologics Fermentation Capacity Market, by Country/Region, 2024-2036 (USD Million)
Table 27. Global Biologics Fermentation Capacity Market, by Country/Region, 2024-2036 (USD Million)
Table 28. North America: Biologics Fermentation Capacity Market, by Country, 2024-2036 (USD Million)
Table 29. North America: Biologics Fermentation Capacity Market, by System Type, 2024-2036 (USD Million)
Table 30. North America: Biologics Fermentation Capacity Market, by Scale of Operation, 2024-2036 (USD Million)
Table 31. North America: Biologics Fermentation Capacity Market, by Mode of Operation, 2024-2036 (USD Million)
Table 32. North America: Biologics Fermentation Capacity Market, by Cell/Organism Type, 2024-2036 (USD Million)
Table 33. North America: Biologics Fermentation Capacity Market, by Application, 2024-2036 (USD Million)
Table 34. North America: Biologics Fermentation Capacity Market, by End User, 2024-2036 (USD Million)
Table 35. U.S.: Biologics Fermentation Capacity Market, by System Type, 2024-2036 (USD Million)
Table 36. U.S.: Biologics Fermentation Capacity Market, by Scale of Operation, 2024-2036 (USD Million)
Table 37. U.S.: Biologics Fermentation Capacity Market, by Mode of Operation, 2024-2036 (USD Million)
Table 38. U.S.: Biologics Fermentation Capacity Market, by Cell/Organism Type, 2024-2036 (USD Million)
Table 39. U.S.: Biologics Fermentation Capacity Market, by Application, 2024-2036 (USD Million)
Table 40. U.S.: Biologics Fermentation Capacity Market, by End User, 2024-2036 (USD Million)
Table 41. Canada: Biologics Fermentation Capacity Market, by System Type, 2024-2036 (USD Million)
Table 42. Canada: Biologics Fermentation Capacity Market, by Scale of Operation, 2024-2036 (USD Million)
Table 43. Canada: Biologics Fermentation Capacity Market, by Mode of Operation, 2024-2036 (USD Million)
Table 44. Canada: Biologics Fermentation Capacity Market, by Cell/Organism Type, 2024-2036 (USD Million)
Table 45. Canada: Biologics Fermentation Capacity Market, by Application, 2024-2036 (USD Million)
Table 46. Canada: Biologics Fermentation Capacity Market, by End User, 2024-2036 (USD Million)
Table 47. Europe: Biologics Fermentation Capacity Market, by Country, 2024-2036 (USD Million)
Table 48. Europe: Biologics Fermentation Capacity Market, by System Type, 2024-2036 (USD Million)
Table 49. Europe: Biologics Fermentation Capacity Market, by Scale of Operation, 2024-2036 (USD Million)
Table 50. Europe: Biologics Fermentation Capacity Market, by Mode of Operation, 2024-2036 (USD Million)
Table 51. Europe: Biologics Fermentation Capacity Market, by Cell/Organism Type, 2024-2036 (USD Million)
Table 52. Europe: Biologics Fermentation Capacity Market, by Application, 2024-2036 (USD Million)
Table 53. Europe: Biologics Fermentation Capacity Market, by End User, 2024-2036 (USD Million)
Table 54. Germany: Biologics Fermentation Capacity Market, by System Type, 2024-2036 (USD Million)
Table 55. Germany: Biologics Fermentation Capacity Market, by Scale of Operation, 2024-2036 (USD Million)
Table 56. Germany: Biologics Fermentation Capacity Market, by Mode of Operation, 2024-2036 (USD Million)
Table 57. Germany: Biologics Fermentation Capacity Market, by Cell/Organism Type, 2024-2036 (USD Million)
Table 58. Germany: Biologics Fermentation Capacity Market, by Application, 2024-2036 (USD Million)
Table 59. Germany: Biologics Fermentation Capacity Market, by End User, 2024-2036 (USD Million)
Table 60. U.K.: Biologics Fermentation Capacity Market, by System Type, 2024-2036 (USD Million)
Table 61. U.K.: Biologics Fermentation Capacity Market, by Scale of Operation, 2024-2036 (USD Million)
Table 62. U.K.: Biologics Fermentation Capacity Market, by Mode of Operation, 2024-2036 (USD Million)
Table 63. U.K.: Biologics Fermentation Capacity Market, by Cell/Organism Type, 2024-2036 (USD Million)
Table 64. U.K.: Biologics Fermentation Capacity Market, by Application, 2024-2036 (USD Million)
Table 65. U.K.: Biologics Fermentation Capacity Market, by End User, 2024-2036 (USD Million)
Table 66. France: Biologics Fermentation Capacity Market, by System Type, 2024-2036 (USD Million)
Table 67. France: Biologics Fermentation Capacity Market, by Scale of Operation, 2024-2036 (USD Million)
Table 68. France: Biologics Fermentation Capacity Market, by Mode of Operation, 2024-2036 (USD Million)
Table 69. France: Biologics Fermentation Capacity Market, by Cell/Organism Type, 2024-2036 (USD Million)
Table 70. France: Biologics Fermentation Capacity Market, by Application, 2024-2036 (USD Million)
Table 71. France: Biologics Fermentation Capacity Market, by End User, 2024-2036 (USD Million)
Table 72. Denmark: Biologics Fermentation Capacity Market, by System Type, 2024-2036 (USD Million)
Table 73. Denmark: Biologics Fermentation Capacity Market, by Scale of Operation, 2024-2036 (USD Million)
Table 74. Denmark: Biologics Fermentation Capacity Market, by Mode of Operation, 2024-2036 (USD Million)
Table 75. Denmark: Biologics Fermentation Capacity Market, by Cell/Organism Type, 2024-2036 (USD Million)
Table 76. Denmark: Biologics Fermentation Capacity Market, by Application, 2024-2036 (USD Million)
Table 77. Denmark: Biologics Fermentation Capacity Market, by End User, 2024-2036 (USD Million)
Table 78. Switzerland: Biologics Fermentation Capacity Market, by System Type, 2024-2036 (USD Million)
Table 79. Switzerland: Biologics Fermentation Capacity Market, by Scale of Operation, 2024-2036 (USD Million)
Table 80. Switzerland: Biologics Fermentation Capacity Market, by Mode of Operation, 2024-2036 (USD Million)
Table 81. Switzerland: Biologics Fermentation Capacity Market, by Cell/Organism Type, 2024-2036 (USD Million)
Table 82. Switzerland: Biologics Fermentation Capacity Market, by Application, 2024-2036 (USD Million)
Table 83. Switzerland: Biologics Fermentation Capacity Market, by End User, 2024-2036 (USD Million)
Table 84. Italy: Biologics Fermentation Capacity Market, by System Type, 2024-2036 (USD Million)
Table 85. Italy: Biologics Fermentation Capacity Market, by Scale of Operation, 2024-2036 (USD Million)
Table 86. Italy: Biologics Fermentation Capacity Market, by Mode of Operation, 2024-2036 (USD Million)
Table 87. Italy: Biologics Fermentation Capacity Market, by Cell/Organism Type, 2024-2036 (USD Million)
Table 88. Italy: Biologics Fermentation Capacity Market, by Application, 2024-2036 (USD Million)
Table 89. Italy: Biologics Fermentation Capacity Market, by End User, 2024-2036 (USD Million)
Table 90. Rest of Europe: Biologics Fermentation Capacity Market, by System Type, 2024-2036 (USD Million)
Table 91. Rest of Europe: Biologics Fermentation Capacity Market, by Scale of Operation, 2024-2036 (USD Million)
Table 92. Rest of Europe: Biologics Fermentation Capacity Market, by Mode of Operation, 2024-2036 (USD Million)
Table 93. Rest of Europe: Biologics Fermentation Capacity Market, by Cell/Organism Type, 2024-2036 (USD Million)
Table 94. Rest of Europe: Biologics Fermentation Capacity Market, by Application, 2024-2036 (USD Million)
Table 95. Rest of Europe: Biologics Fermentation Capacity Market, by End User, 2024-2036 (USD Million)
Table 96. Asia-Pacific: Biologics Fermentation Capacity Market, by Country, 2024-2036 (USD Million)
Table 97. Asia-Pacific: Biologics Fermentation Capacity Market, by System Type, 2024-2036 (USD Million)
Table 98. Asia-Pacific: Biologics Fermentation Capacity Market, by Scale of Operation, 2024-2036 (USD Million)
Table 99. Asia-Pacific: Biologics Fermentation Capacity Market, by Mode of Operation, 2024-2036 (USD Million)
Table 100. Asia-Pacific: Biologics Fermentation Capacity Market, by Cell/Organism Type, 2024-2036 (USD Million)
Table 101. Asia-Pacific: Biologics Fermentation Capacity Market, by Application, 2024-2036 (USD Million)
Table 102. Asia-Pacific: Biologics Fermentation Capacity Market, by End User, 2024-2036 (USD Million)
Table 103. China: Biologics Fermentation Capacity Market, by System Type, 2024-2036 (USD Million)
Table 104. China: Biologics Fermentation Capacity Market, by Scale of Operation, 2024-2036 (USD Million)
Table 105. China: Biologics Fermentation Capacity Market, by Mode of Operation, 2024-2036 (USD Million)
Table 106. China: Biologics Fermentation Capacity Market, by Cell/Organism Type, 2024-2036 (USD Million)
Table 107. China: Biologics Fermentation Capacity Market, by Application, 2024-2036 (USD Million)
Table 108. China: Biologics Fermentation Capacity Market, by End User, 2024-2036 (USD Million)
Table 109. South Korea: Biologics Fermentation Capacity Market, by System Type, 2024-2036 (USD Million)
Table 110. South Korea: Biologics Fermentation Capacity Market, by Scale of Operation, 2024-2036 (USD Million)
Table 111. South Korea: Biologics Fermentation Capacity Market, by Mode of Operation, 2024-2036 (USD Million)
Table 112. South Korea: Biologics Fermentation Capacity Market, by Cell/Organism Type, 2024-2036 (USD Million)
Table 113. South Korea: Biologics Fermentation Capacity Market, by Application, 2024-2036 (USD Million)
Table 114. South Korea: Biologics Fermentation Capacity Market, by End User, 2024-2036 (USD Million)
Table 115. India: Biologics Fermentation Capacity Market, by System Type, 2024-2036 (USD Million)
Table 116. India: Biologics Fermentation Capacity Market, by Scale of Operation, 2024-2036 (USD Million)
Table 117. India: Biologics Fermentation Capacity Market, by Mode of Operation, 2024-2036 (USD Million)
Table 118. India: Biologics Fermentation Capacity Market, by Cell/Organism Type, 2024-2036 (USD Million)
Table 119. India: Biologics Fermentation Capacity Market, by Application, 2024-2036 (USD Million)
Table 120. India: Biologics Fermentation Capacity Market, by End User, 2024-2036 (USD Million)
Table 121. Japan: Biologics Fermentation Capacity Market, by System Type, 2024-2036 (USD Million)
Table 122. Japan: Biologics Fermentation Capacity Market, by Scale of Operation, 2024-2036 (USD Million)
Table 123. Japan: Biologics Fermentation Capacity Market, by Mode of Operation, 2024-2036 (USD Million)
Table 124. Japan: Biologics Fermentation Capacity Market, by Cell/Organism Type, 2024-2036 (USD Million)
Table 125. Japan: Biologics Fermentation Capacity Market, by Application, 2024-2036 (USD Million)
Table 126. Japan: Biologics Fermentation Capacity Market, by End User, 2024-2036 (USD Million)
Table 127. Australia & New Zealand: Biologics Fermentation Capacity Market, by System Type, 2024-2036 (USD Million)
Table 128. Australia & New Zealand: Biologics Fermentation Capacity Market, by Scale of Operation, 2024-2036 (USD Million)
Table 129. Australia & New Zealand: Biologics Fermentation Capacity Market, by Mode of Operation, 2024-2036 (USD Million)
Table 130. Australia & New Zealand: Biologics Fermentation Capacity Market, by Cell/Organism Type, 2024-2036 (USD Million)
Table 131. Australia & New Zealand: Biologics Fermentation Capacity Market, by Application, 2024-2036 (USD Million)
Table 132. Australia & New Zealand: Biologics Fermentation Capacity Market, by End User, 2024-2036 (USD Million)
Table 133. Rest of Asia-Pacific: Biologics Fermentation Capacity Market, by System Type, 2024-2036 (USD Million)
Table 134. Rest of Asia-Pacific: Biologics Fermentation Capacity Market, by Scale of Operation, 2024-2036 (USD Million)
Table 135. Rest of Asia-Pacific: Biologics Fermentation Capacity Market, by Mode of Operation, 2024-2036 (USD Million)
Table 136. Rest of Asia-Pacific: Biologics Fermentation Capacity Market, by Cell/Organism Type, 2024-2036 (USD Million)
Table 137. Rest of Asia-Pacific: Biologics Fermentation Capacity Market, by Application, 2024-2036 (USD Million)
Table 138. Rest of Asia-Pacific: Biologics Fermentation Capacity Market, by End User, 2024-2036 (USD Million)
Table 139. Latin America: Biologics Fermentation Capacity Market, by Country, 2024-2036 (USD Million)
Table 140. Latin America: Biologics Fermentation Capacity Market, by System Type, 2024-2036 (USD Million)
Table 141. Latin America: Biologics Fermentation Capacity Market, by Scale of Operation, 2024-2036 (USD Million)
Table 142. Latin America: Biologics Fermentation Capacity Market, by Mode of Operation, 2024-2036 (USD Million)
Table 143. Latin America: Biologics Fermentation Capacity Market, by Cell/Organism Type, 2024-2036 (USD Million)
Table 144. Latin America: Biologics Fermentation Capacity Market, by Application, 2024-2036 (USD Million)
Table 145. Latin America: Biologics Fermentation Capacity Market, by End User, 2024-2036 (USD Million)
Table 146. Brazil: Biologics Fermentation Capacity Market, by System Type, 2024-2036 (USD Million)
Table 147. Brazil: Biologics Fermentation Capacity Market, by Scale of Operation, 2024-2036 (USD Million)
Table 148. Brazil: Biologics Fermentation Capacity Market, by Mode of Operation, 2024-2036 (USD Million)
Table 149. Brazil: Biologics Fermentation Capacity Market, by Cell/Organism Type, 2024-2036 (USD Million)
Table 150. Brazil: Biologics Fermentation Capacity Market, by Application, 2024-2036 (USD Million)
Table 151. Brazil: Biologics Fermentation Capacity Market, by End User, 2024-2036 (USD Million)
Table 152. Argentina: Biologics Fermentation Capacity Market, by System Type, 2024-2036 (USD Million)
Table 153. Argentina: Biologics Fermentation Capacity Market, by Scale of Operation, 2024-2036 (USD Million)
Table 154. Argentina: Biologics Fermentation Capacity Market, by Mode of Operation, 2024-2036 (USD Million)
Table 155. Argentina: Biologics Fermentation Capacity Market, by Cell/Organism Type, 2024-2036 (USD Million)
Table 156. Argentina: Biologics Fermentation Capacity Market, by Application, 2024-2036 (USD Million)
Table 157. Argentina: Biologics Fermentation Capacity Market, by End User, 2024-2036 (USD Million)
Table 158. Mexico: Biologics Fermentation Capacity Market, by System Type, 2024-2036 (USD Million)
Table 159. Mexico: Biologics Fermentation Capacity Market, by Scale of Operation, 2024-2036 (USD Million)
Table 160. Mexico: Biologics Fermentation Capacity Market, by Mode of Operation, 2024-2036 (USD Million)
Table 161. Mexico: Biologics Fermentation Capacity Market, by Cell/Organism Type, 2024-2036 (USD Million)
Table 162. Mexico: Biologics Fermentation Capacity Market, by Application, 2024-2036 (USD Million)
Table 163. Mexico: Biologics Fermentation Capacity Market, by End User, 2024-2036 (USD Million)
Table 164. Rest of Latin America: Biologics Fermentation Capacity Market, by System Type, 2024-2036 (USD Million)
Table 165. Rest of Latin America: Biologics Fermentation Capacity Market, by Scale of Operation, 2024-2036 (USD Million)
Table 166. Rest of Latin America: Biologics Fermentation Capacity Market, by Mode of Operation, 2024-2036 (USD Million)
Table 167. Rest of Latin America: Biologics Fermentation Capacity Market, by Cell/Organism Type, 2024-2036 (USD Million)
Table 168. Rest of Latin America: Biologics Fermentation Capacity Market, by Application, 2024-2036 (USD Million)
Table 169. Rest of Latin America: Biologics Fermentation Capacity Market, by End User, 2024-2036 (USD Million)
Table 170. Middle East & Africa: Biologics Fermentation Capacity Market, by Country, 2024-2036 (USD Million)
Table 171. Middle East & Africa: Biologics Fermentation Capacity Market, by System Type, 2024-2036 (USD Million)
Table 172. Middle East & Africa: Biologics Fermentation Capacity Market, by Scale of Operation, 2024-2036 (USD Million)
Table 173. Middle East & Africa: Biologics Fermentation Capacity Market, by Mode of Operation, 2024-2036 (USD Million)
Table 174. Middle East & Africa: Biologics Fermentation Capacity Market, by Cell/Organism Type, 2024-2036 (USD Million)
Table 175. Middle East & Africa: Biologics Fermentation Capacity Market, by Application, 2024-2036 (USD Million)
Table 176. Middle East & Africa: Biologics Fermentation Capacity Market, by End User, 2024-2036 (USD Million)
Table 177. Saudi Arabia: Biologics Fermentation Capacity Market, by System Type, 2024-2036 (USD Million)
Table 178. Saudi Arabia: Biologics Fermentation Capacity Market, by Scale of Operation, 2024-2036 (USD Million)
Table 179. Saudi Arabia: Biologics Fermentation Capacity Market, by Mode of Operation, 2024-2036 (USD Million)
Table 180. Saudi Arabia: Biologics Fermentation Capacity Market, by Cell/Organism Type, 2024-2036 (USD Million)
Table 181. Saudi Arabia: Biologics Fermentation Capacity Market, by Application, 2024-2036 (USD Million)
Table 182. Saudi Arabia: Biologics Fermentation Capacity Market, by End User, 2024-2036 (USD Million)
Table 183. UAE: Biologics Fermentation Capacity Market, by System Type, 2024-2036 (USD Million)
Table 184. UAE: Biologics Fermentation Capacity Market, by Scale of Operation, 2024-2036 (USD Million)
Table 185. UAE: Biologics Fermentation Capacity Market, by Mode of Operation, 2024-2036 (USD Million)
Table 186. UAE: Biologics Fermentation Capacity Market, by Cell/Organism Type, 2024-2036 (USD Million)
Table 187. UAE: Biologics Fermentation Capacity Market, by Application, 2024-2036 (USD Million)
Table 188. UAE: Biologics Fermentation Capacity Market, by End User, 2024-2036 (USD Million)
Table 189. South Africa: Biologics Fermentation Capacity Market, by System Type, 2024-2036 (USD Million)
Table 190. South Africa: Biologics Fermentation Capacity Market, by Scale of Operation, 2024-2036 (USD Million)
Table 191. South Africa: Biologics Fermentation Capacity Market, by Mode of Operation, 2024-2036 (USD Million)
Table 192. South Africa: Biologics Fermentation Capacity Market, by Cell/Organism Type, 2024-2036 (USD Million)
Table 193. South Africa: Biologics Fermentation Capacity Market, by Application, 2024-2036 (USD Million)
Table 194. South Africa: Biologics Fermentation Capacity Market, by End User, 2024-2036 (USD Million)
Table 195. Rest of Middle East & Africa: Biologics Fermentation Capacity Market, by System Type, 2024-2036 (USD Million)
Table 196. Rest of Middle East & Africa: Biologics Fermentation Capacity Market, by Scale of Operation, 2024-2036 (USD Million)
Table 197. Rest of Middle East & Africa: Biologics Fermentation Capacity Market, by Mode of Operation, 2024-2036 (USD Million)
Table 198. Rest of Middle East & Africa: Biologics Fermentation Capacity Market, by Cell/Organism Type, 2024-2036 (USD Million)
Table 199. Rest of Middle East & Africa: Biologics Fermentation Capacity Market, by Application, 2024-2036 (USD Million)
Table 200. Rest of Middle East & Africa: Biologics Fermentation Capacity Market, by End User, 2024-2036 (USD Million)
Table 201. Sartorius AG: Product Portfolio
Table 202. Danaher Corporation/Cytiva: Product Portfolio
Table 203. Thermo Fisher Scientific Inc.: Product Portfolio
Table 204. Merck KGaA: Product Portfolio
Table 205. Eppendorf SE: Product Portfolio
Table 206. ABEC, Inc.: Product Portfolio
Table 207. Getinge AB: Product Portfolio
Table 208. Tofflon Science and Technology Group Co., Ltd.: Product Portfolio
Table 209. GEA Group Aktiengesellschaft: Product Portfolio
Table 210. Pierre Guérin: Product Portfolio
Table 211. ZETA GmbH: Product Portfolio
Table 212. Bioengineering AG: Product Portfolio
Table 213. INFORS HT: Product Portfolio
Table 214. PBS Biotech, Inc.: Product Portfolio
Table 215. bbi-biotech GmbH: Product Portfolio
Table 216. Solaris Biotechnology S.r.l.: Product Portfolio
Table 2. Global Biologics Fermentation Capacity Market, by System Type, 2024-2036 (USD Million)
Table 3. Global Single-Use (Disposable) Bioreactor Systems Market, by Country/Region, 2024-2036 (USD Million)
Table 4. Global Stainless Steel (Reusable) Bioreactor Systems Market, by Country/Region, 2024-2036 (USD Million)
Table 5. Global Hybrid Systems Market, by Country/Region, 2024-2036 (USD Million)
Table 6. Global Biologics Fermentation Capacity Market, by Scale of Operation, 2024-2036 (USD Million)
Table 7. Global Bench & Pilot Scale Biologics Fermentation Capacity Market, by Country/Region, 2024-2036 (USD Million)
Table 8. Global Clinical Scale Biologics Fermentation Capacity Market, by Country/Region, 2024-2036 (USD Million)
Table 9. Global Commercial/Large Scale Biologics Fermentation Capacity Market, by Country/Region, 2024-2036 (USD Million)
Table 10. Global Biologics Fermentation Capacity Market, by Mode of Operation, 2024-2036 (USD Million)
Table 11. Global Batch Biologics Fermentation Capacity Market, by Country/Region, 2024-2036 (USD Million)
Table 12. Global Fed-Batch Biologics Fermentation Capacity Market, by Country/Region, 2024-2036 (USD Million)
Table 13. Global Perfusion/Continuous Biologics Fermentation Capacity Market, by Country/Region, 2024-2036 (USD Million)
Table 14. Global Biologics Fermentation Capacity Market, by Cell/Organism Type, 2024-2036 (USD Million)
Table 15. Global Mammalian Cell Culture Biologics Fermentation Capacity Market, by Country/Region, 2024-2036 (USD Million)
Table 16. Global Microbial Fermentation Biologics Fermentation Capacity Market, by Country/Region, 2024-2036 (USD Million)
Table 17. Global Others (Insect Cell, Yeast & Alternative Platforms) Biologics Fermentation Capacity Market, by Country/Region, 2024-2036 (USD Million)
Table 18. Global Biologics Fermentation Capacity Market, by Application, 2024-2036 (USD Million)
Table 19. Global Monoclonal Antibodies & Biosimilars Biologics Fermentation Capacity Market, by Country/Region, 2024-2036 (USD Million)
Table 20. Global Vaccines Biologics Fermentation Capacity Market, by Country/Region, 2024-2036 (USD Million)
Table 21. Global Cell & Gene Therapy Biologics Fermentation Capacity Market, by Country/Region, 2024-2036 (USD Million)
Table 22. Global Recombinant Proteins & Enzymes Biologics Fermentation Capacity Market, by Country/Region, 2024-2036 (USD Million)
Table 23. Global Biologics Fermentation Capacity Market, by End User, 2024-2036 (USD Million)
Table 24. Global CDMOs/CMOs Biologics Fermentation Capacity Market, by Country/Region, 2024-2036 (USD Million)
Table 25. Global Biopharmaceutical & Biotechnology Companies Biologics Fermentation Capacity Market, by Country/Region, 2024-2036 (USD Million)
Table 26. Global Academic & Research Institutes Biologics Fermentation Capacity Market, by Country/Region, 2024-2036 (USD Million)
Table 27. Global Biologics Fermentation Capacity Market, by Country/Region, 2024-2036 (USD Million)
Table 28. North America: Biologics Fermentation Capacity Market, by Country, 2024-2036 (USD Million)
Table 29. North America: Biologics Fermentation Capacity Market, by System Type, 2024-2036 (USD Million)
Table 30. North America: Biologics Fermentation Capacity Market, by Scale of Operation, 2024-2036 (USD Million)
Table 31. North America: Biologics Fermentation Capacity Market, by Mode of Operation, 2024-2036 (USD Million)
Table 32. North America: Biologics Fermentation Capacity Market, by Cell/Organism Type, 2024-2036 (USD Million)
Table 33. North America: Biologics Fermentation Capacity Market, by Application, 2024-2036 (USD Million)
Table 34. North America: Biologics Fermentation Capacity Market, by End User, 2024-2036 (USD Million)
Table 35. U.S.: Biologics Fermentation Capacity Market, by System Type, 2024-2036 (USD Million)
Table 36. U.S.: Biologics Fermentation Capacity Market, by Scale of Operation, 2024-2036 (USD Million)
Table 37. U.S.: Biologics Fermentation Capacity Market, by Mode of Operation, 2024-2036 (USD Million)
Table 38. U.S.: Biologics Fermentation Capacity Market, by Cell/Organism Type, 2024-2036 (USD Million)
Table 39. U.S.: Biologics Fermentation Capacity Market, by Application, 2024-2036 (USD Million)
Table 40. U.S.: Biologics Fermentation Capacity Market, by End User, 2024-2036 (USD Million)
Table 41. Canada: Biologics Fermentation Capacity Market, by System Type, 2024-2036 (USD Million)
Table 42. Canada: Biologics Fermentation Capacity Market, by Scale of Operation, 2024-2036 (USD Million)
Table 43. Canada: Biologics Fermentation Capacity Market, by Mode of Operation, 2024-2036 (USD Million)
Table 44. Canada: Biologics Fermentation Capacity Market, by Cell/Organism Type, 2024-2036 (USD Million)
Table 45. Canada: Biologics Fermentation Capacity Market, by Application, 2024-2036 (USD Million)
Table 46. Canada: Biologics Fermentation Capacity Market, by End User, 2024-2036 (USD Million)
Table 47. Europe: Biologics Fermentation Capacity Market, by Country, 2024-2036 (USD Million)
Table 48. Europe: Biologics Fermentation Capacity Market, by System Type, 2024-2036 (USD Million)
Table 49. Europe: Biologics Fermentation Capacity Market, by Scale of Operation, 2024-2036 (USD Million)
Table 50. Europe: Biologics Fermentation Capacity Market, by Mode of Operation, 2024-2036 (USD Million)
Table 51. Europe: Biologics Fermentation Capacity Market, by Cell/Organism Type, 2024-2036 (USD Million)
Table 52. Europe: Biologics Fermentation Capacity Market, by Application, 2024-2036 (USD Million)
Table 53. Europe: Biologics Fermentation Capacity Market, by End User, 2024-2036 (USD Million)
Table 54. Germany: Biologics Fermentation Capacity Market, by System Type, 2024-2036 (USD Million)
Table 55. Germany: Biologics Fermentation Capacity Market, by Scale of Operation, 2024-2036 (USD Million)
Table 56. Germany: Biologics Fermentation Capacity Market, by Mode of Operation, 2024-2036 (USD Million)
Table 57. Germany: Biologics Fermentation Capacity Market, by Cell/Organism Type, 2024-2036 (USD Million)
Table 58. Germany: Biologics Fermentation Capacity Market, by Application, 2024-2036 (USD Million)
Table 59. Germany: Biologics Fermentation Capacity Market, by End User, 2024-2036 (USD Million)
Table 60. U.K.: Biologics Fermentation Capacity Market, by System Type, 2024-2036 (USD Million)
Table 61. U.K.: Biologics Fermentation Capacity Market, by Scale of Operation, 2024-2036 (USD Million)
Table 62. U.K.: Biologics Fermentation Capacity Market, by Mode of Operation, 2024-2036 (USD Million)
Table 63. U.K.: Biologics Fermentation Capacity Market, by Cell/Organism Type, 2024-2036 (USD Million)
Table 64. U.K.: Biologics Fermentation Capacity Market, by Application, 2024-2036 (USD Million)
Table 65. U.K.: Biologics Fermentation Capacity Market, by End User, 2024-2036 (USD Million)
Table 66. France: Biologics Fermentation Capacity Market, by System Type, 2024-2036 (USD Million)
Table 67. France: Biologics Fermentation Capacity Market, by Scale of Operation, 2024-2036 (USD Million)
Table 68. France: Biologics Fermentation Capacity Market, by Mode of Operation, 2024-2036 (USD Million)
Table 69. France: Biologics Fermentation Capacity Market, by Cell/Organism Type, 2024-2036 (USD Million)
Table 70. France: Biologics Fermentation Capacity Market, by Application, 2024-2036 (USD Million)
Table 71. France: Biologics Fermentation Capacity Market, by End User, 2024-2036 (USD Million)
Table 72. Denmark: Biologics Fermentation Capacity Market, by System Type, 2024-2036 (USD Million)
Table 73. Denmark: Biologics Fermentation Capacity Market, by Scale of Operation, 2024-2036 (USD Million)
Table 74. Denmark: Biologics Fermentation Capacity Market, by Mode of Operation, 2024-2036 (USD Million)
Table 75. Denmark: Biologics Fermentation Capacity Market, by Cell/Organism Type, 2024-2036 (USD Million)
Table 76. Denmark: Biologics Fermentation Capacity Market, by Application, 2024-2036 (USD Million)
Table 77. Denmark: Biologics Fermentation Capacity Market, by End User, 2024-2036 (USD Million)
Table 78. Switzerland: Biologics Fermentation Capacity Market, by System Type, 2024-2036 (USD Million)
Table 79. Switzerland: Biologics Fermentation Capacity Market, by Scale of Operation, 2024-2036 (USD Million)
Table 80. Switzerland: Biologics Fermentation Capacity Market, by Mode of Operation, 2024-2036 (USD Million)
Table 81. Switzerland: Biologics Fermentation Capacity Market, by Cell/Organism Type, 2024-2036 (USD Million)
Table 82. Switzerland: Biologics Fermentation Capacity Market, by Application, 2024-2036 (USD Million)
Table 83. Switzerland: Biologics Fermentation Capacity Market, by End User, 2024-2036 (USD Million)
Table 84. Italy: Biologics Fermentation Capacity Market, by System Type, 2024-2036 (USD Million)
Table 85. Italy: Biologics Fermentation Capacity Market, by Scale of Operation, 2024-2036 (USD Million)
Table 86. Italy: Biologics Fermentation Capacity Market, by Mode of Operation, 2024-2036 (USD Million)
Table 87. Italy: Biologics Fermentation Capacity Market, by Cell/Organism Type, 2024-2036 (USD Million)
Table 88. Italy: Biologics Fermentation Capacity Market, by Application, 2024-2036 (USD Million)
Table 89. Italy: Biologics Fermentation Capacity Market, by End User, 2024-2036 (USD Million)
Table 90. Rest of Europe: Biologics Fermentation Capacity Market, by System Type, 2024-2036 (USD Million)
Table 91. Rest of Europe: Biologics Fermentation Capacity Market, by Scale of Operation, 2024-2036 (USD Million)
Table 92. Rest of Europe: Biologics Fermentation Capacity Market, by Mode of Operation, 2024-2036 (USD Million)
Table 93. Rest of Europe: Biologics Fermentation Capacity Market, by Cell/Organism Type, 2024-2036 (USD Million)
Table 94. Rest of Europe: Biologics Fermentation Capacity Market, by Application, 2024-2036 (USD Million)
Table 95. Rest of Europe: Biologics Fermentation Capacity Market, by End User, 2024-2036 (USD Million)
Table 96. Asia-Pacific: Biologics Fermentation Capacity Market, by Country, 2024-2036 (USD Million)
Table 97. Asia-Pacific: Biologics Fermentation Capacity Market, by System Type, 2024-2036 (USD Million)
Table 98. Asia-Pacific: Biologics Fermentation Capacity Market, by Scale of Operation, 2024-2036 (USD Million)
Table 99. Asia-Pacific: Biologics Fermentation Capacity Market, by Mode of Operation, 2024-2036 (USD Million)
Table 100. Asia-Pacific: Biologics Fermentation Capacity Market, by Cell/Organism Type, 2024-2036 (USD Million)
Table 101. Asia-Pacific: Biologics Fermentation Capacity Market, by Application, 2024-2036 (USD Million)
Table 102. Asia-Pacific: Biologics Fermentation Capacity Market, by End User, 2024-2036 (USD Million)
Table 103. China: Biologics Fermentation Capacity Market, by System Type, 2024-2036 (USD Million)
Table 104. China: Biologics Fermentation Capacity Market, by Scale of Operation, 2024-2036 (USD Million)
Table 105. China: Biologics Fermentation Capacity Market, by Mode of Operation, 2024-2036 (USD Million)
Table 106. China: Biologics Fermentation Capacity Market, by Cell/Organism Type, 2024-2036 (USD Million)
Table 107. China: Biologics Fermentation Capacity Market, by Application, 2024-2036 (USD Million)
Table 108. China: Biologics Fermentation Capacity Market, by End User, 2024-2036 (USD Million)
Table 109. South Korea: Biologics Fermentation Capacity Market, by System Type, 2024-2036 (USD Million)
Table 110. South Korea: Biologics Fermentation Capacity Market, by Scale of Operation, 2024-2036 (USD Million)
Table 111. South Korea: Biologics Fermentation Capacity Market, by Mode of Operation, 2024-2036 (USD Million)
Table 112. South Korea: Biologics Fermentation Capacity Market, by Cell/Organism Type, 2024-2036 (USD Million)
Table 113. South Korea: Biologics Fermentation Capacity Market, by Application, 2024-2036 (USD Million)
Table 114. South Korea: Biologics Fermentation Capacity Market, by End User, 2024-2036 (USD Million)
Table 115. India: Biologics Fermentation Capacity Market, by System Type, 2024-2036 (USD Million)
Table 116. India: Biologics Fermentation Capacity Market, by Scale of Operation, 2024-2036 (USD Million)
Table 117. India: Biologics Fermentation Capacity Market, by Mode of Operation, 2024-2036 (USD Million)
Table 118. India: Biologics Fermentation Capacity Market, by Cell/Organism Type, 2024-2036 (USD Million)
Table 119. India: Biologics Fermentation Capacity Market, by Application, 2024-2036 (USD Million)
Table 120. India: Biologics Fermentation Capacity Market, by End User, 2024-2036 (USD Million)
Table 121. Japan: Biologics Fermentation Capacity Market, by System Type, 2024-2036 (USD Million)
Table 122. Japan: Biologics Fermentation Capacity Market, by Scale of Operation, 2024-2036 (USD Million)
Table 123. Japan: Biologics Fermentation Capacity Market, by Mode of Operation, 2024-2036 (USD Million)
Table 124. Japan: Biologics Fermentation Capacity Market, by Cell/Organism Type, 2024-2036 (USD Million)
Table 125. Japan: Biologics Fermentation Capacity Market, by Application, 2024-2036 (USD Million)
Table 126. Japan: Biologics Fermentation Capacity Market, by End User, 2024-2036 (USD Million)
Table 127. Australia & New Zealand: Biologics Fermentation Capacity Market, by System Type, 2024-2036 (USD Million)
Table 128. Australia & New Zealand: Biologics Fermentation Capacity Market, by Scale of Operation, 2024-2036 (USD Million)
Table 129. Australia & New Zealand: Biologics Fermentation Capacity Market, by Mode of Operation, 2024-2036 (USD Million)
Table 130. Australia & New Zealand: Biologics Fermentation Capacity Market, by Cell/Organism Type, 2024-2036 (USD Million)
Table 131. Australia & New Zealand: Biologics Fermentation Capacity Market, by Application, 2024-2036 (USD Million)
Table 132. Australia & New Zealand: Biologics Fermentation Capacity Market, by End User, 2024-2036 (USD Million)
Table 133. Rest of Asia-Pacific: Biologics Fermentation Capacity Market, by System Type, 2024-2036 (USD Million)
Table 134. Rest of Asia-Pacific: Biologics Fermentation Capacity Market, by Scale of Operation, 2024-2036 (USD Million)
Table 135. Rest of Asia-Pacific: Biologics Fermentation Capacity Market, by Mode of Operation, 2024-2036 (USD Million)
Table 136. Rest of Asia-Pacific: Biologics Fermentation Capacity Market, by Cell/Organism Type, 2024-2036 (USD Million)
Table 137. Rest of Asia-Pacific: Biologics Fermentation Capacity Market, by Application, 2024-2036 (USD Million)
Table 138. Rest of Asia-Pacific: Biologics Fermentation Capacity Market, by End User, 2024-2036 (USD Million)
Table 139. Latin America: Biologics Fermentation Capacity Market, by Country, 2024-2036 (USD Million)
Table 140. Latin America: Biologics Fermentation Capacity Market, by System Type, 2024-2036 (USD Million)
Table 141. Latin America: Biologics Fermentation Capacity Market, by Scale of Operation, 2024-2036 (USD Million)
Table 142. Latin America: Biologics Fermentation Capacity Market, by Mode of Operation, 2024-2036 (USD Million)
Table 143. Latin America: Biologics Fermentation Capacity Market, by Cell/Organism Type, 2024-2036 (USD Million)
Table 144. Latin America: Biologics Fermentation Capacity Market, by Application, 2024-2036 (USD Million)
Table 145. Latin America: Biologics Fermentation Capacity Market, by End User, 2024-2036 (USD Million)
Table 146. Brazil: Biologics Fermentation Capacity Market, by System Type, 2024-2036 (USD Million)
Table 147. Brazil: Biologics Fermentation Capacity Market, by Scale of Operation, 2024-2036 (USD Million)
Table 148. Brazil: Biologics Fermentation Capacity Market, by Mode of Operation, 2024-2036 (USD Million)
Table 149. Brazil: Biologics Fermentation Capacity Market, by Cell/Organism Type, 2024-2036 (USD Million)
Table 150. Brazil: Biologics Fermentation Capacity Market, by Application, 2024-2036 (USD Million)
Table 151. Brazil: Biologics Fermentation Capacity Market, by End User, 2024-2036 (USD Million)
Table 152. Argentina: Biologics Fermentation Capacity Market, by System Type, 2024-2036 (USD Million)
Table 153. Argentina: Biologics Fermentation Capacity Market, by Scale of Operation, 2024-2036 (USD Million)
Table 154. Argentina: Biologics Fermentation Capacity Market, by Mode of Operation, 2024-2036 (USD Million)
Table 155. Argentina: Biologics Fermentation Capacity Market, by Cell/Organism Type, 2024-2036 (USD Million)
Table 156. Argentina: Biologics Fermentation Capacity Market, by Application, 2024-2036 (USD Million)
Table 157. Argentina: Biologics Fermentation Capacity Market, by End User, 2024-2036 (USD Million)
Table 158. Mexico: Biologics Fermentation Capacity Market, by System Type, 2024-2036 (USD Million)
Table 159. Mexico: Biologics Fermentation Capacity Market, by Scale of Operation, 2024-2036 (USD Million)
Table 160. Mexico: Biologics Fermentation Capacity Market, by Mode of Operation, 2024-2036 (USD Million)
Table 161. Mexico: Biologics Fermentation Capacity Market, by Cell/Organism Type, 2024-2036 (USD Million)
Table 162. Mexico: Biologics Fermentation Capacity Market, by Application, 2024-2036 (USD Million)
Table 163. Mexico: Biologics Fermentation Capacity Market, by End User, 2024-2036 (USD Million)
Table 164. Rest of Latin America: Biologics Fermentation Capacity Market, by System Type, 2024-2036 (USD Million)
Table 165. Rest of Latin America: Biologics Fermentation Capacity Market, by Scale of Operation, 2024-2036 (USD Million)
Table 166. Rest of Latin America: Biologics Fermentation Capacity Market, by Mode of Operation, 2024-2036 (USD Million)
Table 167. Rest of Latin America: Biologics Fermentation Capacity Market, by Cell/Organism Type, 2024-2036 (USD Million)
Table 168. Rest of Latin America: Biologics Fermentation Capacity Market, by Application, 2024-2036 (USD Million)
Table 169. Rest of Latin America: Biologics Fermentation Capacity Market, by End User, 2024-2036 (USD Million)
Table 170. Middle East & Africa: Biologics Fermentation Capacity Market, by Country, 2024-2036 (USD Million)
Table 171. Middle East & Africa: Biologics Fermentation Capacity Market, by System Type, 2024-2036 (USD Million)
Table 172. Middle East & Africa: Biologics Fermentation Capacity Market, by Scale of Operation, 2024-2036 (USD Million)
Table 173. Middle East & Africa: Biologics Fermentation Capacity Market, by Mode of Operation, 2024-2036 (USD Million)
Table 174. Middle East & Africa: Biologics Fermentation Capacity Market, by Cell/Organism Type, 2024-2036 (USD Million)
Table 175. Middle East & Africa: Biologics Fermentation Capacity Market, by Application, 2024-2036 (USD Million)
Table 176. Middle East & Africa: Biologics Fermentation Capacity Market, by End User, 2024-2036 (USD Million)
Table 177. Saudi Arabia: Biologics Fermentation Capacity Market, by System Type, 2024-2036 (USD Million)
Table 178. Saudi Arabia: Biologics Fermentation Capacity Market, by Scale of Operation, 2024-2036 (USD Million)
Table 179. Saudi Arabia: Biologics Fermentation Capacity Market, by Mode of Operation, 2024-2036 (USD Million)
Table 180. Saudi Arabia: Biologics Fermentation Capacity Market, by Cell/Organism Type, 2024-2036 (USD Million)
Table 181. Saudi Arabia: Biologics Fermentation Capacity Market, by Application, 2024-2036 (USD Million)
Table 182. Saudi Arabia: Biologics Fermentation Capacity Market, by End User, 2024-2036 (USD Million)
Table 183. UAE: Biologics Fermentation Capacity Market, by System Type, 2024-2036 (USD Million)
Table 184. UAE: Biologics Fermentation Capacity Market, by Scale of Operation, 2024-2036 (USD Million)
Table 185. UAE: Biologics Fermentation Capacity Market, by Mode of Operation, 2024-2036 (USD Million)
Table 186. UAE: Biologics Fermentation Capacity Market, by Cell/Organism Type, 2024-2036 (USD Million)
Table 187. UAE: Biologics Fermentation Capacity Market, by Application, 2024-2036 (USD Million)
Table 188. UAE: Biologics Fermentation Capacity Market, by End User, 2024-2036 (USD Million)
Table 189. South Africa: Biologics Fermentation Capacity Market, by System Type, 2024-2036 (USD Million)
Table 190. South Africa: Biologics Fermentation Capacity Market, by Scale of Operation, 2024-2036 (USD Million)
Table 191. South Africa: Biologics Fermentation Capacity Market, by Mode of Operation, 2024-2036 (USD Million)
Table 192. South Africa: Biologics Fermentation Capacity Market, by Cell/Organism Type, 2024-2036 (USD Million)
Table 193. South Africa: Biologics Fermentation Capacity Market, by Application, 2024-2036 (USD Million)
Table 194. South Africa: Biologics Fermentation Capacity Market, by End User, 2024-2036 (USD Million)
Table 195. Rest of Middle East & Africa: Biologics Fermentation Capacity Market, by System Type, 2024-2036 (USD Million)
Table 196. Rest of Middle East & Africa: Biologics Fermentation Capacity Market, by Scale of Operation, 2024-2036 (USD Million)
Table 197. Rest of Middle East & Africa: Biologics Fermentation Capacity Market, by Mode of Operation, 2024-2036 (USD Million)
Table 198. Rest of Middle East & Africa: Biologics Fermentation Capacity Market, by Cell/Organism Type, 2024-2036 (USD Million)
Table 199. Rest of Middle East & Africa: Biologics Fermentation Capacity Market, by Application, 2024-2036 (USD Million)
Table 200. Rest of Middle East & Africa: Biologics Fermentation Capacity Market, by End User, 2024-2036 (USD Million)
Table 201. Sartorius AG: Product Portfolio
Table 202. Danaher Corporation/Cytiva: Product Portfolio
Table 203. Thermo Fisher Scientific Inc.: Product Portfolio
Table 204. Merck KGaA: Product Portfolio
Table 205. Eppendorf SE: Product Portfolio
Table 206. ABEC, Inc.: Product Portfolio
Table 207. Getinge AB: Product Portfolio
Table 208. Tofflon Science and Technology Group Co., Ltd.: Product Portfolio
Table 209. GEA Group Aktiengesellschaft: Product Portfolio
Table 210. Pierre Guérin: Product Portfolio
Table 211. ZETA GmbH: Product Portfolio
Table 212. Bioengineering AG: Product Portfolio
Table 213. INFORS HT: Product Portfolio
Table 214. PBS Biotech, Inc.: Product Portfolio
Table 215. bbi-biotech GmbH: Product Portfolio
Table 216. Solaris Biotechnology S.r.l.: Product Portfolio
List of Figures
Figure 1. Biologics Fermentation Capacity Market, Segmentation and Scope
Figure 2. Research Process
Figure 3. Secondary Sources Referenced for This Study
Figure 4. Primary Research Techniques
Figure 5. Key Executives Interviewed
Figure 6. Breakdown of Primary Interviews (Supply-Side and Demand-Side, by Region)
Figure 7. Market Sizing and Growth Forecast Approach
Figure 8. Executive Summary: Global Biologics Fermentation Capacity Market, by System Type, 2026 Vs. 2036 (USD Million)
Figure 9. Executive Summary: Global Biologics Fermentation Capacity Market, by Scale of Operation, 2026 Vs. 2036 (USD Million)
Figure 10. Executive Summary: Global Biologics Fermentation Capacity Market, by Mode of Operation, 2026 Vs. 2036 (USD Million)
Figure 11. Executive Summary: Global Biologics Fermentation Capacity Market, by Cell/Organism Type, 2026 Vs. 2036 (USD Million)
Figure 12. Executive Summary: Global Biologics Fermentation Capacity Market, by Application, 2026 Vs. 2036 (USD Million)
Figure 13. Executive Summary: Global Biologics Fermentation Capacity Market, by End User, 2026 Vs. 2036 (USD Million)
Figure 14. Global Biologics Fermentation Capacity Market, by Geography
Figure 15. Biologics Fermentation Capacity Market: Competitive Dashboard
Figure 16. Evolution of Bioreactor and Fermenter Technology for Biologics Manufacturing
Figure 17. Biologics Fermentation Capacity Market, Factors Affecting Market Growth
Figure 18. FDA Novel Drug Approvals and Biologics, 2023-2025
Figure 19. Single-Use Bioreactor Platforms and Working Volumes, by Supplier
Figure 20. Announced U.S. Manufacturing Investment Commitments by Drug Manufacturers, 2025
Figure 21. Capital Investment in Large-Scale Biologics Capacity Projects
Figure 22. Bioreactor Platforms for Cell and Gene Therapy and Next-Generation Modalities
Figure 23. Emerging-Market Biomanufacturing Capacity Projects
Figure 24. Workforce Requirements for New Biomanufacturing Capacity
Figure 25. Hybrid Facility Design: Single-Use and Stainless-Steel Equipment in One Production Train
Figure 26. Fed-Batch, Intensified Fed-Batch and Perfusion Processes
Figure 27. Key Vendor Selection Criteria
Figure 28. Use Cases for Bioreactor and Fermenter Systems
Figure 29. Porter's Five Forces Analysis
Figure 30. Biologics Fermentation Capacity Market, Value Chain Analysis
Figure 31. Single-Use Vs. Stainless-Steel: Capital and Operating Cost Comparison
Figure 32. Bioreactor Platform Technologies: Stirred-Tank, Single-Use, Vertical-Wheel and Advanced Therapy Systems
Figure 33. Facility Design and Commissioning Timeline: Stainless-Steel Vs. Single-Use and Modular Facilities
Figure 34. Regulatory Frameworks Affecting Biologics Fermentation Capacity
Figure 35. Government Programmes Supporting Biomanufacturing Capacity
Figure 36. PESTEL Analysis of the Biologics Fermentation Capacity Market
Figure 37. Bioreactor System Types: Single-Use, Stainless Steel and Hybrid
Figure 38. Global Biologics Fermentation Capacity Market, by System Type, 2026 Vs. 2036 (USD Million)
Figure 39. Global Biologics Fermentation Capacity Market, by System Type, 2024-2036 (USD Million)
Figure 40. Single-Use Bioreactor Platforms and Maximum Working Volumes, by Supplier
Figure 41. Global Single-Use (Disposable) Bioreactor Systems Market, by Country/Region, 2024-2036 (USD Million)
Figure 42. Large-Scale Stainless-Steel Bioreactor Capacity, by Site
Figure 43. Global Stainless Steel (Reusable) Bioreactor Systems Market, by Country/Region, 2024-2036 (USD Million)
Figure 44. Hybrid Production Train: Single-Use Seed Bioreactors and Stainless-Steel Production Bioreactors
Figure 45. Global Hybrid Systems Market, by Country/Region, 2024-2036 (USD Million)
Figure 46. Bioreactor Scales from Process Development to Commercial Production
Figure 47. Global Biologics Fermentation Capacity Market, by Scale of Operation, 2026 Vs. 2036 (USD Million)
Figure 48. Global Biologics Fermentation Capacity Market, by Scale of Operation, 2024-2036 (USD Million)
Figure 49. Bench and Pilot Bioreactor Systems: Formats and Uses
Figure 50. Global Bench & Pilot Scale Biologics Fermentation Capacity Market, by Country/Region, 2024-2036 (USD Million)
Figure 51. Clinical Manufacturing with Single-Use Bioreactors
Figure 52. Global Clinical Scale Biologics Fermentation Capacity Market, by Country/Region, 2024-2036 (USD Million)
Figure 53. Commercial-Scale Capacity Projects, by Company and Site
Figure 54. Global Commercial/Large Scale Biologics Fermentation Capacity Market, by Country/Region, 2024-2036 (USD Million)
Figure 55. Batch, Fed-Batch and Perfusion Processes: Feeding, Harvest and Cell Density
Figure 56. Global Biologics Fermentation Capacity Market, by Mode of Operation, 2026 Vs. 2036 (USD Million)
Figure 57. Global Biologics Fermentation Capacity Market, by Mode of Operation, 2024-2036 (USD Million)
Figure 58. Batch Operation in Seed Trains, Vaccines and Microbial Fermentation
Figure 59. Global Batch Biologics Fermentation Capacity Market, by Country/Region, 2024-2036 (USD Million)
Figure 60. Fed-Batch Production in Stainless-Steel and Single-Use Bioreactors
Figure 61. Global Fed-Batch Biologics Fermentation Capacity Market, by Country/Region, 2024-2036 (USD Million)
Figure 62. Perfusion Bioreactor with Cell Retention and Continuous Harvest
Figure 63. Global Perfusion/Continuous Biologics Fermentation Capacity Market, by Country/Region, 2024-2036 (USD Million)
Figure 64. Expression Platforms for Biologics: Mammalian, Microbial, Yeast and Insect Cells
Figure 65. Global Biologics Fermentation Capacity Market, by Cell/Organism Type, 2026 Vs. 2036 (USD Million)
Figure 66. Global Biologics Fermentation Capacity Market, by Cell/Organism Type, 2024-2036 (USD Million)
Figure 67. Mammalian Bioreactor Capacity: Antibodies, Biosimilars and Viral Vectors
Figure 68. Global Mammalian Cell Culture Biologics Fermentation Capacity Market, by Country/Region, 2024-2036 (USD Million)
Figure 69. Microbial Fermentation: Products, Fermenter Requirements and Capacity Projects
Figure 70. Global Microbial Fermentation Biologics Fermentation Capacity Market, by Country/Region, 2024-2036 (USD Million)
Figure 71. Yeast, Insect Cell and Alternative Expression Platforms: Products and Bioreactor Requirements
Figure 72. Global Others (Insect Cell, Yeast & Alternative Platforms) Biologics Fermentation Capacity Market, by Country/Region, 2024-2036 (USD Million)
Figure 73. Bioreactor Requirements by Application: Antibodies, Vaccines, Cell and Gene Therapy and Recombinant Proteins
Figure 74. Global Biologics Fermentation Capacity Market, by Application, 2026 Vs. 2036 (USD Million)
Figure 75. Global Biologics Fermentation Capacity Market, by Application, 2024-2036 (USD Million)
Figure 76. Antibody and Biosimilar Manufacturing Capacity, by Site
Figure 77. Global Monoclonal Antibodies & Biosimilars Biologics Fermentation Capacity Market, by Country/Region, 2024-2036 (USD Million)
Figure 78. Vaccine Production Platforms and Bioreactor Types
Figure 79. Global Vaccines Biologics Fermentation Capacity Market, by Country/Region, 2024-2036 (USD Million)
Figure 80. Cell and Gene Therapy Manufacturing: Cell Expansion and Viral Vector Bioreactors
Figure 81. Global Cell & Gene Therapy Biologics Fermentation Capacity Market, by Country/Region, 2024-2036 (USD Million)
Figure 82. Recombinant Protein and Enzyme Production by Platform
Figure 83. Global Recombinant Proteins & Enzymes Biologics Fermentation Capacity Market, by Country/Region, 2024-2036 (USD Million)
Figure 84. End Users of Bioreactor and Fermenter Systems and Their Purchasing Patterns
Figure 85. Global Biologics Fermentation Capacity Market, by End User, 2026 Vs. 2036 (USD Million)
Figure 86. Global Biologics Fermentation Capacity Market, by End User, 2024-2036 (USD Million)
Figure 87. CDMO Capacity Expansions, by Company and Site
Figure 88. Global CDMOs/CMOs Biologics Fermentation Capacity Market, by Country/Region, 2024-2036 (USD Million)
Figure 89. Drug Manufacturer Biomanufacturing Investments, 2023-2026
Figure 90. Global Biopharmaceutical & Biotechnology Companies Biologics Fermentation Capacity Market, by Country/Region, 2024-2036 (USD Million)
Figure 91. Bioreactor Use in Academic Research, Training and Translational Manufacturing
Figure 92. Global Academic & Research Institutes Biologics Fermentation Capacity Market, by Country/Region, 2024-2036 (USD Million)
Figure 93. Global Biologics Fermentation Capacity Market, by Geography, 2026 Vs. 2036 (USD Million)
Figure 94. Global Biologics Fermentation Capacity Market, by Geography, 2024-2036 (USD Million)
Figure 95. Global Biologics Fermentation Capacity Market: Geographic Snapshot
Figure 96. North America: Biologics Fermentation Capacity Market Snapshot
Figure 97. North America: Biologics Fermentation Capacity Market, by Country, 2024-2036 (USD Million)
Figure 98. U.S. Biomanufacturing Investment Commitments and Capacity Projects, 2024-2026
Figure 99. Canada: Biomanufacturing and Life Sciences Strategy Projects
Figure 100. Europe: Biologics Fermentation Capacity Market Snapshot
Figure 101. Europe: Biologics Fermentation Capacity Market, by Country, 2024-2036 (USD Million)
Figure 102. Germany: Biopharmaceutical Manufacturing Sites and Bioreactor Suppliers
Figure 103. U.K.: Biomanufacturing Investments and Vaccine Partnerships
Figure 104. France: Sanofi Bioproduction Investments
Figure 105. Denmark: Hillerød and Kalundborg Capacity Expansions
Figure 106. Switzerland: Large-Scale Biologics Sites and Bioreactor Suppliers
Figure 107. Italy: Pharmaceutical Production, Exports and Investment, 2025
Figure 108. Rest of Europe: Biologics Manufacturing Sites
Figure 109. Asia-Pacific: Biologics Fermentation Capacity Market Snapshot
Figure 110. Asia-Pacific: Biologics Fermentation Capacity Market, by Country, 2024-2036 (USD Million)
Figure 111. China: Innovative Drug Approvals and Out-Licensing, 2024-2025
Figure 112. South Korea: Songdo Biologics Capacity, by Company
Figure 113. India: Government Programmes Supporting Fermentation and Biomanufacturing
Figure 114. Japan: METI Dual-Use Biopharmaceutical Manufacturing Projects
Figure 115. Australia: Sovereign Vaccine Manufacturing Facilities
Figure 116. Rest of Asia-Pacific: Biologics Manufacturing Hubs
Figure 117. Latin America: Biologics Fermentation Capacity Market Snapshot
Figure 118. Latin America: Biologics Fermentation Capacity Market, by Country, 2024-2036 (USD Million)
Figure 119. Brazil: Public Vaccine and Biologics Production Projects
Figure 120. Argentina: Biosimilar and Vaccine Manufacturing
Figure 121. Mexico: Biologics and Vaccine Manufacturing Initiatives
Figure 122. Rest of Latin America: Biomanufacturing Initiatives
Figure 123. Middle East & Africa: Biologics Fermentation Capacity Market Snapshot
Figure 124. Middle East & Africa: Biologics Fermentation Capacity Market, by Country, 2024-2036 (USD Million)
Figure 125. Saudi Arabia: National Biotechnology Strategy and Biomanufacturing Projects
Figure 126. United Arab Emirates: Biomanufacturing Facilities and Investors
Figure 127. South Africa: Vaccine Manufacturing Expansion
Figure 128. Rest of Middle East & Africa: Vaccine and Biologics Manufacturing Projects
Figure 129. Biologics Fermentation Capacity Market: Competitive Structure
Figure 130. Key Growth Strategies Adopted by Leading Market Players, 2025-2026
Figure 131. Strategic Developments, by Company, 2025-2026
Figure 132. Biologics Fermentation Capacity Market: Competitive Benchmarking, by System Type Coverage
Figure 133. Biologics Fermentation Capacity Market: Competitive Benchmarking, by Scale Range
Figure 134. Biologics Fermentation Capacity Market: Competitive Benchmarking, by Facility Footprint
Figure 135. Biologics Fermentation Capacity Market: Competitive Benchmarking, by Registered Geographies
Figure 136. Competitive Dashboard: Biologics Fermentation Capacity Market
Figure 137. Global Biologics Fermentation Capacity Market Share Analysis, by Key Players (2025)
Figure 138. Top Five Players: Bioreactor Portfolio and Basis of Position, 2025
Figure 139. Sartorius AG: Company Snapshot
Figure 140. Sartorius AG: SWOT Analysis
Figure 141. Danaher Corporation/Cytiva: Company Snapshot
Figure 142. Danaher Corporation/Cytiva: SWOT Analysis
Figure 143. Thermo Fisher Scientific Inc.: Company Snapshot
Figure 144. Thermo Fisher Scientific Inc.: SWOT Analysis
Figure 145. Merck KGaA: Company Snapshot
Figure 146. Merck KGaA: SWOT Analysis
Figure 147. Eppendorf SE: Company Snapshot
Figure 148. Eppendorf SE: SWOT Analysis
Figure 149. ABEC, Inc.: Company Snapshot
Figure 150. ABEC, Inc.: SWOT Analysis
Figure 151. Getinge AB: Company Snapshot
Figure 152. Getinge AB: SWOT Analysis
Figure 153. Tofflon Science and Technology Group Co., Ltd.: Company Snapshot
Figure 154. Tofflon Science and Technology Group Co., Ltd.: SWOT Analysis
Figure 155. GEA Group Aktiengesellschaft: Company Snapshot
Figure 156. GEA Group Aktiengesellschaft: SWOT Analysis
Figure 157. Pierre Guérin: Company Snapshot
Figure 158. Pierre Guérin: SWOT Analysis
Figure 159. ZETA GmbH: Company Snapshot
Figure 160. ZETA GmbH: SWOT Analysis
Figure 161. Bioengineering AG: Company Snapshot
Figure 162. Bioengineering AG: SWOT Analysis
Figure 163. INFORS HT: Company Snapshot
Figure 164. INFORS HT: SWOT Analysis
Figure 165. PBS Biotech, Inc.: Company Snapshot
Figure 166. PBS Biotech, Inc.: SWOT Analysis
Figure 167. bbi-biotech GmbH: Company Snapshot
Figure 168. bbi-biotech GmbH: SWOT Analysis
Figure 169. Solaris Biotechnology S.r.l.: Company Snapshot
Figure 170. Solaris Biotechnology S.r.l.: SWOT Analysis
Figure 2. Research Process
Figure 3. Secondary Sources Referenced for This Study
Figure 4. Primary Research Techniques
Figure 5. Key Executives Interviewed
Figure 6. Breakdown of Primary Interviews (Supply-Side and Demand-Side, by Region)
Figure 7. Market Sizing and Growth Forecast Approach
Figure 8. Executive Summary: Global Biologics Fermentation Capacity Market, by System Type, 2026 Vs. 2036 (USD Million)
Figure 9. Executive Summary: Global Biologics Fermentation Capacity Market, by Scale of Operation, 2026 Vs. 2036 (USD Million)
Figure 10. Executive Summary: Global Biologics Fermentation Capacity Market, by Mode of Operation, 2026 Vs. 2036 (USD Million)
Figure 11. Executive Summary: Global Biologics Fermentation Capacity Market, by Cell/Organism Type, 2026 Vs. 2036 (USD Million)
Figure 12. Executive Summary: Global Biologics Fermentation Capacity Market, by Application, 2026 Vs. 2036 (USD Million)
Figure 13. Executive Summary: Global Biologics Fermentation Capacity Market, by End User, 2026 Vs. 2036 (USD Million)
Figure 14. Global Biologics Fermentation Capacity Market, by Geography
Figure 15. Biologics Fermentation Capacity Market: Competitive Dashboard
Figure 16. Evolution of Bioreactor and Fermenter Technology for Biologics Manufacturing
Figure 17. Biologics Fermentation Capacity Market, Factors Affecting Market Growth
Figure 18. FDA Novel Drug Approvals and Biologics, 2023-2025
Figure 19. Single-Use Bioreactor Platforms and Working Volumes, by Supplier
Figure 20. Announced U.S. Manufacturing Investment Commitments by Drug Manufacturers, 2025
Figure 21. Capital Investment in Large-Scale Biologics Capacity Projects
Figure 22. Bioreactor Platforms for Cell and Gene Therapy and Next-Generation Modalities
Figure 23. Emerging-Market Biomanufacturing Capacity Projects
Figure 24. Workforce Requirements for New Biomanufacturing Capacity
Figure 25. Hybrid Facility Design: Single-Use and Stainless-Steel Equipment in One Production Train
Figure 26. Fed-Batch, Intensified Fed-Batch and Perfusion Processes
Figure 27. Key Vendor Selection Criteria
Figure 28. Use Cases for Bioreactor and Fermenter Systems
Figure 29. Porter's Five Forces Analysis
Figure 30. Biologics Fermentation Capacity Market, Value Chain Analysis
Figure 31. Single-Use Vs. Stainless-Steel: Capital and Operating Cost Comparison
Figure 32. Bioreactor Platform Technologies: Stirred-Tank, Single-Use, Vertical-Wheel and Advanced Therapy Systems
Figure 33. Facility Design and Commissioning Timeline: Stainless-Steel Vs. Single-Use and Modular Facilities
Figure 34. Regulatory Frameworks Affecting Biologics Fermentation Capacity
Figure 35. Government Programmes Supporting Biomanufacturing Capacity
Figure 36. PESTEL Analysis of the Biologics Fermentation Capacity Market
Figure 37. Bioreactor System Types: Single-Use, Stainless Steel and Hybrid
Figure 38. Global Biologics Fermentation Capacity Market, by System Type, 2026 Vs. 2036 (USD Million)
Figure 39. Global Biologics Fermentation Capacity Market, by System Type, 2024-2036 (USD Million)
Figure 40. Single-Use Bioreactor Platforms and Maximum Working Volumes, by Supplier
Figure 41. Global Single-Use (Disposable) Bioreactor Systems Market, by Country/Region, 2024-2036 (USD Million)
Figure 42. Large-Scale Stainless-Steel Bioreactor Capacity, by Site
Figure 43. Global Stainless Steel (Reusable) Bioreactor Systems Market, by Country/Region, 2024-2036 (USD Million)
Figure 44. Hybrid Production Train: Single-Use Seed Bioreactors and Stainless-Steel Production Bioreactors
Figure 45. Global Hybrid Systems Market, by Country/Region, 2024-2036 (USD Million)
Figure 46. Bioreactor Scales from Process Development to Commercial Production
Figure 47. Global Biologics Fermentation Capacity Market, by Scale of Operation, 2026 Vs. 2036 (USD Million)
Figure 48. Global Biologics Fermentation Capacity Market, by Scale of Operation, 2024-2036 (USD Million)
Figure 49. Bench and Pilot Bioreactor Systems: Formats and Uses
Figure 50. Global Bench & Pilot Scale Biologics Fermentation Capacity Market, by Country/Region, 2024-2036 (USD Million)
Figure 51. Clinical Manufacturing with Single-Use Bioreactors
Figure 52. Global Clinical Scale Biologics Fermentation Capacity Market, by Country/Region, 2024-2036 (USD Million)
Figure 53. Commercial-Scale Capacity Projects, by Company and Site
Figure 54. Global Commercial/Large Scale Biologics Fermentation Capacity Market, by Country/Region, 2024-2036 (USD Million)
Figure 55. Batch, Fed-Batch and Perfusion Processes: Feeding, Harvest and Cell Density
Figure 56. Global Biologics Fermentation Capacity Market, by Mode of Operation, 2026 Vs. 2036 (USD Million)
Figure 57. Global Biologics Fermentation Capacity Market, by Mode of Operation, 2024-2036 (USD Million)
Figure 58. Batch Operation in Seed Trains, Vaccines and Microbial Fermentation
Figure 59. Global Batch Biologics Fermentation Capacity Market, by Country/Region, 2024-2036 (USD Million)
Figure 60. Fed-Batch Production in Stainless-Steel and Single-Use Bioreactors
Figure 61. Global Fed-Batch Biologics Fermentation Capacity Market, by Country/Region, 2024-2036 (USD Million)
Figure 62. Perfusion Bioreactor with Cell Retention and Continuous Harvest
Figure 63. Global Perfusion/Continuous Biologics Fermentation Capacity Market, by Country/Region, 2024-2036 (USD Million)
Figure 64. Expression Platforms for Biologics: Mammalian, Microbial, Yeast and Insect Cells
Figure 65. Global Biologics Fermentation Capacity Market, by Cell/Organism Type, 2026 Vs. 2036 (USD Million)
Figure 66. Global Biologics Fermentation Capacity Market, by Cell/Organism Type, 2024-2036 (USD Million)
Figure 67. Mammalian Bioreactor Capacity: Antibodies, Biosimilars and Viral Vectors
Figure 68. Global Mammalian Cell Culture Biologics Fermentation Capacity Market, by Country/Region, 2024-2036 (USD Million)
Figure 69. Microbial Fermentation: Products, Fermenter Requirements and Capacity Projects
Figure 70. Global Microbial Fermentation Biologics Fermentation Capacity Market, by Country/Region, 2024-2036 (USD Million)
Figure 71. Yeast, Insect Cell and Alternative Expression Platforms: Products and Bioreactor Requirements
Figure 72. Global Others (Insect Cell, Yeast & Alternative Platforms) Biologics Fermentation Capacity Market, by Country/Region, 2024-2036 (USD Million)
Figure 73. Bioreactor Requirements by Application: Antibodies, Vaccines, Cell and Gene Therapy and Recombinant Proteins
Figure 74. Global Biologics Fermentation Capacity Market, by Application, 2026 Vs. 2036 (USD Million)
Figure 75. Global Biologics Fermentation Capacity Market, by Application, 2024-2036 (USD Million)
Figure 76. Antibody and Biosimilar Manufacturing Capacity, by Site
Figure 77. Global Monoclonal Antibodies & Biosimilars Biologics Fermentation Capacity Market, by Country/Region, 2024-2036 (USD Million)
Figure 78. Vaccine Production Platforms and Bioreactor Types
Figure 79. Global Vaccines Biologics Fermentation Capacity Market, by Country/Region, 2024-2036 (USD Million)
Figure 80. Cell and Gene Therapy Manufacturing: Cell Expansion and Viral Vector Bioreactors
Figure 81. Global Cell & Gene Therapy Biologics Fermentation Capacity Market, by Country/Region, 2024-2036 (USD Million)
Figure 82. Recombinant Protein and Enzyme Production by Platform
Figure 83. Global Recombinant Proteins & Enzymes Biologics Fermentation Capacity Market, by Country/Region, 2024-2036 (USD Million)
Figure 84. End Users of Bioreactor and Fermenter Systems and Their Purchasing Patterns
Figure 85. Global Biologics Fermentation Capacity Market, by End User, 2026 Vs. 2036 (USD Million)
Figure 86. Global Biologics Fermentation Capacity Market, by End User, 2024-2036 (USD Million)
Figure 87. CDMO Capacity Expansions, by Company and Site
Figure 88. Global CDMOs/CMOs Biologics Fermentation Capacity Market, by Country/Region, 2024-2036 (USD Million)
Figure 89. Drug Manufacturer Biomanufacturing Investments, 2023-2026
Figure 90. Global Biopharmaceutical & Biotechnology Companies Biologics Fermentation Capacity Market, by Country/Region, 2024-2036 (USD Million)
Figure 91. Bioreactor Use in Academic Research, Training and Translational Manufacturing
Figure 92. Global Academic & Research Institutes Biologics Fermentation Capacity Market, by Country/Region, 2024-2036 (USD Million)
Figure 93. Global Biologics Fermentation Capacity Market, by Geography, 2026 Vs. 2036 (USD Million)
Figure 94. Global Biologics Fermentation Capacity Market, by Geography, 2024-2036 (USD Million)
Figure 95. Global Biologics Fermentation Capacity Market: Geographic Snapshot
Figure 96. North America: Biologics Fermentation Capacity Market Snapshot
Figure 97. North America: Biologics Fermentation Capacity Market, by Country, 2024-2036 (USD Million)
Figure 98. U.S. Biomanufacturing Investment Commitments and Capacity Projects, 2024-2026
Figure 99. Canada: Biomanufacturing and Life Sciences Strategy Projects
Figure 100. Europe: Biologics Fermentation Capacity Market Snapshot
Figure 101. Europe: Biologics Fermentation Capacity Market, by Country, 2024-2036 (USD Million)
Figure 102. Germany: Biopharmaceutical Manufacturing Sites and Bioreactor Suppliers
Figure 103. U.K.: Biomanufacturing Investments and Vaccine Partnerships
Figure 104. France: Sanofi Bioproduction Investments
Figure 105. Denmark: Hillerød and Kalundborg Capacity Expansions
Figure 106. Switzerland: Large-Scale Biologics Sites and Bioreactor Suppliers
Figure 107. Italy: Pharmaceutical Production, Exports and Investment, 2025
Figure 108. Rest of Europe: Biologics Manufacturing Sites
Figure 109. Asia-Pacific: Biologics Fermentation Capacity Market Snapshot
Figure 110. Asia-Pacific: Biologics Fermentation Capacity Market, by Country, 2024-2036 (USD Million)
Figure 111. China: Innovative Drug Approvals and Out-Licensing, 2024-2025
Figure 112. South Korea: Songdo Biologics Capacity, by Company
Figure 113. India: Government Programmes Supporting Fermentation and Biomanufacturing
Figure 114. Japan: METI Dual-Use Biopharmaceutical Manufacturing Projects
Figure 115. Australia: Sovereign Vaccine Manufacturing Facilities
Figure 116. Rest of Asia-Pacific: Biologics Manufacturing Hubs
Figure 117. Latin America: Biologics Fermentation Capacity Market Snapshot
Figure 118. Latin America: Biologics Fermentation Capacity Market, by Country, 2024-2036 (USD Million)
Figure 119. Brazil: Public Vaccine and Biologics Production Projects
Figure 120. Argentina: Biosimilar and Vaccine Manufacturing
Figure 121. Mexico: Biologics and Vaccine Manufacturing Initiatives
Figure 122. Rest of Latin America: Biomanufacturing Initiatives
Figure 123. Middle East & Africa: Biologics Fermentation Capacity Market Snapshot
Figure 124. Middle East & Africa: Biologics Fermentation Capacity Market, by Country, 2024-2036 (USD Million)
Figure 125. Saudi Arabia: National Biotechnology Strategy and Biomanufacturing Projects
Figure 126. United Arab Emirates: Biomanufacturing Facilities and Investors
Figure 127. South Africa: Vaccine Manufacturing Expansion
Figure 128. Rest of Middle East & Africa: Vaccine and Biologics Manufacturing Projects
Figure 129. Biologics Fermentation Capacity Market: Competitive Structure
Figure 130. Key Growth Strategies Adopted by Leading Market Players, 2025-2026
Figure 131. Strategic Developments, by Company, 2025-2026
Figure 132. Biologics Fermentation Capacity Market: Competitive Benchmarking, by System Type Coverage
Figure 133. Biologics Fermentation Capacity Market: Competitive Benchmarking, by Scale Range
Figure 134. Biologics Fermentation Capacity Market: Competitive Benchmarking, by Facility Footprint
Figure 135. Biologics Fermentation Capacity Market: Competitive Benchmarking, by Registered Geographies
Figure 136. Competitive Dashboard: Biologics Fermentation Capacity Market
Figure 137. Global Biologics Fermentation Capacity Market Share Analysis, by Key Players (2025)
Figure 138. Top Five Players: Bioreactor Portfolio and Basis of Position, 2025
Figure 139. Sartorius AG: Company Snapshot
Figure 140. Sartorius AG: SWOT Analysis
Figure 141. Danaher Corporation/Cytiva: Company Snapshot
Figure 142. Danaher Corporation/Cytiva: SWOT Analysis
Figure 143. Thermo Fisher Scientific Inc.: Company Snapshot
Figure 144. Thermo Fisher Scientific Inc.: SWOT Analysis
Figure 145. Merck KGaA: Company Snapshot
Figure 146. Merck KGaA: SWOT Analysis
Figure 147. Eppendorf SE: Company Snapshot
Figure 148. Eppendorf SE: SWOT Analysis
Figure 149. ABEC, Inc.: Company Snapshot
Figure 150. ABEC, Inc.: SWOT Analysis
Figure 151. Getinge AB: Company Snapshot
Figure 152. Getinge AB: SWOT Analysis
Figure 153. Tofflon Science and Technology Group Co., Ltd.: Company Snapshot
Figure 154. Tofflon Science and Technology Group Co., Ltd.: SWOT Analysis
Figure 155. GEA Group Aktiengesellschaft: Company Snapshot
Figure 156. GEA Group Aktiengesellschaft: SWOT Analysis
Figure 157. Pierre Guérin: Company Snapshot
Figure 158. Pierre Guérin: SWOT Analysis
Figure 159. ZETA GmbH: Company Snapshot
Figure 160. ZETA GmbH: SWOT Analysis
Figure 161. Bioengineering AG: Company Snapshot
Figure 162. Bioengineering AG: SWOT Analysis
Figure 163. INFORS HT: Company Snapshot
Figure 164. INFORS HT: SWOT Analysis
Figure 165. PBS Biotech, Inc.: Company Snapshot
Figure 166. PBS Biotech, Inc.: SWOT Analysis
Figure 167. bbi-biotech GmbH: Company Snapshot
Figure 168. bbi-biotech GmbH: SWOT Analysis
Figure 169. Solaris Biotechnology S.r.l.: Company Snapshot
Figure 170. Solaris Biotechnology S.r.l.: SWOT Analysis
Companies Mentioned
- Sartorius AG
- Danaher Corporation/Cytiva
- Thermo Fisher Scientific Inc.
- Merck KGaA
- Eppendorf SE
- ABEC, Inc.
- Getinge AB
- Tofflon Science and Technology Co., Ltd.
- GEA Group Aktiengesellschaft
- Pierre Guérin
- ZETA GmbH
- Bioengineering AG
- INFORS HT
- PBS Biotech, Inc.
- bbi-biotech GmbH
- Solaris Biotech Solutions S.r.l. (Italy).
